Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

norgine ag - dantrolenum natricum hemiheptahydricum - soluzione iniettabile - praeparatio sicca: dantrolenum natricum 20 mg, mannitolum, natrii hydroxidum pro vitro. - myotonolyticum: maligne hyperthermie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

norgine ag - dantrolenum natricum hemiheptahydricum - capsule - dantrolenum natricum 25 mg, tritici amylum 38 mg corresp. glutenum max. 3.8 µg, lactosum monohydricum 169 mg, talcum, magnesii stearas, kapselhülle: e 127, e 171, e 172 (flavum), gelatina, pro capsula. - myotonolyticum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

norgine ag - dantrolenum natricum hemiheptahydricum - capsule - dantrolenum natricum 50 mg, maydis amylum, lactosum monohydricum 65 mg, talcum, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), e 127, e 104, e 172 (rubrum), e 172 (nigrum), pro capsula. - myotonolyticum - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

norgine italia s.r.l. - dantrolene e derivati - dantrolene e derivati

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

nobel pharma schweiz ag - memantinum, natrium - compresse rivestite con film - memantini hydrochloridum 20 mg corresp. memantinum 16.62 mg, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium 0.56 mg, talcum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - la malattia di alzheimer - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - amlodipinum - compresse - amlodipinum 5 mg ut amlodipini besilas, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum a corresp. natrium 168 µg, magnesii stearas, pro compresso. - calciumantagonist - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - amlodipinum - compresse - amlodipinum 10 mg ut amlodipini besilas, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum a corresp. natrium 336 µg, magnesii stearas, pro compresso. - calciumantagonist - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - amlodipinum - compresse - amlodipinum 5 mg ut amlodipini besilas, carboxymethylamylum natricum a corresp. natrium max. 0.168 mg, calcii hydrogenophosphas, cellulosum microcristallinum, magnesii stearas, pro compresso. - calciumantagonist - synthetika